Acute Bacterial Sinusitis Treatment Guidelines

First-Line Treatment Recommendations

The American Academy of Otolaryngology-Head and Neck Surgery recommends amoxicillin as the first-line empiric treatment for uncomplicated acute bacterial sinusitis in most patients 1
For patients with more severe disease or risk factors for resistant organisms, the American Academy of Otolaryngology-Head and Neck Surgery prefers high-dose amoxicillin-clavulanate (1.75-4g/250mg per day in adults) 2, 3
The typical duration of antibiotic therapy for acute bacterial sinusitis is 10-14 days, though some experts suggest continuing treatment until the patient is symptom-free plus 7 additional days 4

The American Academy of Pediatrics states that azithromycin should not be used to treat acute bacterial sinusitis in persons with penicillin hypersensitivity due to resistance patterns 5
Macrolides, including azithromycin, are relatively weak against penicillin-resistant Haemophilus influenzae and Streptococcus pneumoniae, which are common pathogens in sinusitis 4, 6
Surveillance studies have demonstrated resistance of pneumococcus and H. influenzae to azithromycin, making it unsuitable for empiric treatment 5

For patients with penicillin allergy, the American Academy of Otolaryngology-Head and Neck Surgery recommends alternatives such as cefdinir, cefuroxime, or cefpodoxime (for non-type 1 allergies) 5, 2
Respiratory fluoroquinolones (levofloxacin, moxifloxacin, gatifloxacin) are recommended for adults with true penicillin allergy 2, 7

If there is no clinical improvement within 3-5 days of initiating antimicrobial therapy, an alternative antibiotic should be considered 4
For patients who fail initial therapy, broader-spectrum antibiotics should be considered, such as high-dose amoxicillin-clavulanate or respiratory fluoroquinolones 3

The American Academy of Otolaryngology-Head and Neck Surgery recommends comfort measures such as adequate rest, hydration, analgesics, warm facial packs, steamy showers, and sleeping with the head elevated 3
Intranasal saline irrigation and intranasal corticosteroids may be beneficial as adjunctive therapies 8

The American Academy of Family Physicians advises against using azithromycin for empiric treatment of sinusitis due to high resistance rates 5
The American Academy of Allergy, Asthma, and Immunology recommends avoiding antihistamines in acute bacterial sinusitis unless the underlying risk factor is allergic rhinitis 9
Unnecessary imaging studies (plain radiography, CT, MRI) should be avoided to differentiate acute bacterial sinusitis from viral upper respiratory infection 5

The American Academy of Otolaryngology-Head and Neck Surgery recommends doxycycline as an alternative option for penicillin-allergic patients, but it has limited effectiveness against the major pathogens of acute bacterial sinusitis with potential bacterial failure rates of 20-25% 10
For patients with more severe disease or risk factors for resistant organisms, high-dose amoxicillin-clavulanate is preferred, with a calculated clinical efficacy of 90-92% 11

The major pathogens in acute bacterial sinusitis are Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis, and doxycycline has suboptimal coverage against these pathogens compared to first-line agents 10, 12
Tetracyclines are not recommended for the treatment of Group A Streptococcus because high levels of resistance exist to these agents 12

According to the therapeutic outcomes model, antibiotics can be ranked by predicted clinical efficacy for adult patients with acute bacterial sinusitis, with doxycycline having a predicted clinical efficacy of 77-81% 10, 11

Doxycycline may be considered in adult patients with β-lactam allergies who cannot tolerate respiratory fluoroquinolones, but patients should be closely monitored for clinical response, with consideration of switching therapy if no improvement is seen after 72 hours 10, 11

Azithromycin has a predicted clinical efficacy of only 77-81% for acute bacterial sinusitis, significantly lower than first-line options, according to the American Academy of Otolaryngology-Head and Neck Surgery 13
First-line options have higher predicted clinical efficacy (87-91%) compared to azithromycin (77%), as stated by the American Academy of Otolaryngology-Head and Neck Surgery 13

For patients with more severe disease or risk factors for resistant organisms, high-dose amoxicillin-clavulanate is preferred, with a higher predicted clinical efficacy, as recommended by the American Academy of Otolaryngology-Head and Neck Surgery 13

Failure to respond to antimicrobial therapy after 72 hours should prompt either a switch to alternate antimicrobial therapy or reevaluation of the patient, as suggested by the American Academy of Otolaryngology-Head and Neck Surgery 13
When changing antibiotics due to treatment failure, consider the limitations in coverage of the initial agent, according to the American Academy of Otolaryngology-Head and Neck Surgery 13
Patients who have received effective antibiotic therapy and continue to be symptomatic need further evaluation, potentially including CT scan, fiberoptic endoscopy, or sinus aspiration for culture, as recommended by the American Academy of Otolaryngology-Head and Neck Surgery 14